Roy, Utah Clinical Trials

A listing of Roy, Utah clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 122 clinical trials
featured
ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Adult Subjects with Recurrent Clostridioides difficile Infection (RCDI)

ECOSPOR IV is a Phase 3, multicenter, Open Label study to evaluate the safety and tolerability of SER-109 in adult subjects with recurrent CDI.

clostridium difficile
Care Access Research
 (4.5 away) Contact site
  • 37 views
  • 21 Dec, 2020
  • +76 other locations
featured
VIVID-1, a clinical research study for adults 18–80 with moderately to severely active Crohn’s disease.

A phase 3 research study of an injectable investigational medicine for adults ages 18 to 80 with moderate to severe Crohn’s disease. Note that study participants may receive the investigational medication, a currently approved Crohn’s medication, or placebo. The study comprises four periods: screening, treatment period 1, treatment period 2, …

crohn's disease
inflammatory bowel disease
gastrointestinal disorder
gastrointestinal diseases
VIVID-1 Study Center
 (7.1 away) Contact site
  • 66 views
  • 09 Jun, 2021
  • +74 other locations
featured
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis
atopic dermatitis/eczema
eczema
dermatitis
ADVANCED RESEARCH INSTITUTE
 (2.5 away) Contact site
  • 379 views
  • 14 Dec, 2020
  • +22 other locations
featured
A study for patients with influenza to evaluate a new diagnostic device.

A study for patients with influenza to evaluate a new diagnostic device.

Wee Care Pediatrics - Midland
 (1.0 away) Contact site
  • 192 views
  • 23 Nov, 2020
  • 1 location
featured
A study in Pediatric patients Aged = 6 Years to 18 Years with Functional Constipation.

A study in Pediatric patients Aged = 6 Years to 18 Years with Functional Constipation.

Wee Care Pediatrics - Syracuse
 (5.3 away) Contact site
  • 170 views
  • 25 Mar, 2021
  • 1 location
Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

This is a 2-part randomized, double-blind, placebo-controlled study of APT-1011 in adults and adolescents (12 years) with EoE. Part A will evaluate the efficacy and safety of APT-1011 3 mg administered HS for the induction of response to treatment (histologic and symptomatic) over 12 weeks. Part B will evaluate histological …

dysphagia
esophagogastroduodenoscopy
Advanced Research Institute - Ogden
 (2.5 away) Contact site
  • 93 views
  • 14 Jun, 2021
  • +141 other locations
GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants

The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks through 12 months of age, when administered concomitantly with Pneumococcal conjugate vaccine (PCV 13) and other recommended routine infant vaccines(RIV).

bexsero
varivax
pneumococcal
vaccination
conjugate vaccine
GSK Investigational Site
 (1.1 away) Contact site
  • 112 views
  • 12 Jun, 2021
  • +42 other locations
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]

This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etripamil NS self-administered by patients who experience an episode of paroxysmal ventricular tachycardia (PSVT) in an at-home setting. Part 1 comprised the conduct of the NODE-301 study up to the date of the adjudication …

Alpine Research Organization, Inc
 (5.8 away) Contact site
  • 281 views
  • 05 May, 2021
  • +127 other locations
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)

The study is to evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Teriflunomide (Aubagio), administered orally once daily in participants with Relapsing Multiple Sclerosis (RMS).

teriflunomide
aubagio
evobrutinib
Research Site 676
 (6.5 away) Contact site
  • 0 views
  • 14 May, 2021
  • +243 other locations
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evaluate the efficacy and safety of CC- 93538 in adult and adolescent participants with eosinophilic esophagitis (EoE). The study will incorporate a 24-week Induction Phase followed by a 24-week Maintenance Phase. Participants will be …

Advanced Research Institute-South Ogden
 (2.0 away) Contact site
  • 0 views
  • 02 May, 2021
  • +200 other locations